Literature DB >> 2346305

The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane.

R Henriksson1, L Bjermer, E Von Schoultz, K Grankvist.   

Abstract

Estramustine (EM), a complex between estradiol-17 beta and nornitrogen mustard, is commonly used in the treatment of prostatic cancer. The exact mechanism of action is unknown but has previously been considered to be mediated through non-DNA targets, specifically with the mitotic spindle, and to be related to the intact EM complex. In the present study, using different cell-systems (monocyte phagocytosis transformed fibroblasts, colon cancer cells), the EM cytotoxicity was also found to involve direct interaxtion with DNA and cell membranes. The interaction with DNA was shown by a DNA precipitation assay using 3H- and 14C- thymidine, and the cell membrane damage by using 86Rb- accumulation as a sensitive marker for active potassium uptake. EM effects in the fibroblasts were inhibited by various metal chelators and radical scavengers. Involvement of free oxygen radicals was further indicated in a cell-free system with an oxygen electrode. The EM inhibition of monocyte phagocytosis was related to the engulfment, and was not at all influenced by radical scavengers. In contrast to EM, neither of its components alone, or together, affected monocyte engulfment. Finally, it was shown that the colon cancer cell-line HT-29 was resistant to both of the two suggested and separate mechanisms for EM toxicity: an interaction with the microtubuli system by the intact EM complex and a more unspecific action mediated by free-oxygen radicals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346305

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Pharmacokinetics and pharmacodynamics of estramustine phosphate.

Authors:  A T Bergenheim; R Henriksson
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

Review 2.  Estramustine in malignant glioma.

Authors:  A T Bergenheim; R Henriksson; J M Piepmeier; D Yoshida
Journal:  J Neurooncol       Date:  1996-10       Impact factor: 4.130

3.  Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion.

Authors:  P Behnam-Motlagh; O Jonsson; K G Engström; R Henriksson; K Grankvist
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 4.  The role of Snail in prostate cancer.

Authors:  Bethany N Smith; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

Review 5.  Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.

Authors:  C M Perry; D McTavish
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

6.  Radiosensitizing effect of estramustine in malignant glioma in vitro and in vivo.

Authors:  A T Bergenheim; B Zackrisson; J Elfverson; G Roos; R Henriksson
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

7.  DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death.

Authors:  C Vallbo; T Bergenheim; A Bergh; K Grankvist; R Henriksson
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.